Membrane and membrane-associated proteins involved in the aggressive phenotype displayed by highly invasive cancer cells

Proteomics

Volumn 8, Issue 19, 2008, Pages 4054-4065

  Dowling, Paul ^a   Walsh, Naomi ^a   Clynes, Martin ^a  

^a DUBLIN CITY UNIVERSITY   (Ireland)

Author keywords

Integrins; Invasion; Markers; Membrane; Receptors

Indexed keywords

ACTIN; ADH 1; ANTINEOPLASTIC AGENT; CADHERIN; CELL ADHESION MOLECULE; CETUXIMAB; CHEMOKINE RECEPTOR CXCR4 ANTAGONIST; CTCE 9908; ERLOTINIB; GALECTIN; GALECTIN 3; GEFITINIB; HERMES ANTIGEN; IMMUNOGLOBULIN; INTEGRIN; MONOCLONAL ANTIBODY LM 609; N (3 CHLOROPHENYL) 3 [3,5 DIMETHYL 4 (4 METHYL 1 PIPERAZINYLCARBONYL) 1H PYRROL 2 YLMETHYLENE] 2,3 DIHYDRO N METHYL 2 OXO 1H INDOLE 5 SULFONAMIDE; PANITUMUMAB; PSK 1404; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

BONE METASTASIS; BREAST CANCER; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL MIGRATION; EXTRACELLULAR MATRIX; FUNCTIONAL PROTEOMICS; HUMAN; IN VITRO STUDY; MELANOMA; METASTASIS; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR GROWTH;

ANIMALS; HUMANS; INTEGRINS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASMS; PROTEOMICS;

EID: 55749111003     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200800098     Document Type: Review

References (77)

1. Ray, J. M., Stetler-Stevenson, W. G., The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur. Respir. J. 1994, 7, 2062-2072.
2. Deryugina, E. I., Bourdon, M. A., Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. J. Cell Sci. 1996, 109, 643-652.
3. Stetler-Stevenson, W. G., Aznavoorian, S., Liotta, L. A., Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 2003, 9, 541-573.
4. Albini, A., Iwamoto, Y., Kleinman, H. K., Martin, G. R. et al., A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987, 47, 3239-3245.
5. Glynn, S. A., Gammell, P., Heenan, M., O'Connor, R. et al., A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin. Br. J. Cancer 2004, 15, 1800-1807.
6. Felding-Habermann, B., Integrin adhesion receptors in tumor metastasis. Clin. Exp. Metastasis 2003, 20, 203-213.
7. Han, J., Jenq, W., Kefalides, N. A., Integrin alpha2beta1 recognizes laminin-2 and induces C-erb B2 tyrosine phosphorylation in metastatic human melanoma cells. Connect. Tissue Res. 1999, 40, 283-293.
8. Chen, R., Yi, E. C., Donohoe, D., Pan, S. et al., Pancreatic cancer proteome: The proteins that underlie invasion, metastasis, and immunologic escape. Gastroenterology 2005, 129, 1187-1197.
9. Keshamouni, V. G., Michailidis, G., Grasso, C. S., Anthwal, S., Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals amigratory/invasive phenotype. J. Proteome Res. 2006, 5, 1143-1154.
10. Sato, H., Takino, T., Okada, Y., Cao, J. et al., A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994, 370, 61-65.
11. Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L. et al., Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 1995, 270, 5331-5338.
12. Collier, I. E., Wilhelm, S. M., Eisen, A. Z., Marmer, B. L. et al., H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J. Biol. Chem. 1988, 263, 6579-6587.
13. Cortes-Reynosa, P., Robledo, T., Macias-Silva, M., Wu, S. V., Salazar, E. P., Src kinase regulates metalloproteinase-9 secretion induced by type IV collagen in MCF-7 human breast cancer cells. Matrix Biol. 2008, 27, 220-231.
14. Margheri, F., D'Alessio, S., Serratí, S., Pucci, M. et al., Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases. Gene Ther. 2005, 12, 702-714.
15. Tsuboi, K., Shimura, T., Masuda, N., Ide, M. et al., Galectin-3 expression in colorectal cancer: Relation to invasion and metastasis. Anticancer Res. 2007, 27, 2289-2296.
16. Chiang, W. F., Liu, S. Y., Fang, L. Y., Lin, C. N. et al., Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma. Oral Oncol. 2008, 44, 325-334.
17. O'Driscoll, L., Linehan, R., Liang, Y. H., Joyce, H. et al., Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro. Anticancer Res. 2002, 22, 3117-3125.
18. Dowling, P., Meleady, P., Dowd, A., Henry, M. et al., Proteomic analysis of isolated membrane fractions from superinvasive cancer cells. Biochim. Biophys. Acta 2007, 1774, 93-101.
19. Charalabopoulos, K., Papalimneou, V., Charalabopoulos, A., Adhesion molecules in lung cancer. Exp. Oncol. 2003, 25, 16-21.
20. Yuecheng, Y., Hongmei, L., Xiaoyan, X., Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer. Clin. Exp. Metastasis 2006, 23, 65-74.
21. Yi, D., Kyoon, J., Kyu, Y., Yeob, S. et al., E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis. J. Surg. Oncol. 2007, 96, 429-435.
22. Cavallaro, U., Christofori, G., Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 2004, 4, 118-132.
23. Jiang, D., Ying, W., Lu, Y., Wan, J. et al., Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics 2003, 3, 724-737.
24. Vermeulen, S. J., Nollet, F., Teugels, E., Vennekens, K. M. et al., The alphaE-catenin gene (CTNNA1) acts as an invasion-suppressor gene in human colon cancer cells. Oncogene 1999, 18, 905-915.
25. Strathdee, G., Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin. Cancer Biol. 2002, 12, 373-379.
26. Batlle, E., Sancho, E., Francí, C., Domínguez, D. et al., The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2002, 2, 84-89.
27. Tomita, K., van Bokhoven, A., van Leenders, G. J., Ruijter, E. T. et al., Cadherin switching in human prostate cancer progression. Cancer Res. 2000, 60, 3650-3654.
28. Skubitz, A. P., Adhesion molecules. Cancer Treat. Res. 2002, 107, 305-329.
29. Kaiser, U., Auerbach, B., Oldenburg, M., The neural cell adhesion molecule NCAM in multiple myeloma. Leuk. Lymphoma 1996, 20, 389-395.
30. Perl, A. K., Dahl, U., Wilgenbus, P., Cremer, H. et al., Reduced expression of neural cell adhesion molecule induces metastatic dissemination of pancreatic beta tumor cells. Nat. Med. 1999, 5, 286-291.
31. Cavallaro, U., Niedermeyer, J., Fuxa, M., Christofori, G., NCAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling. Nat. Cell Biol. 2001, 3, 650-657.
32. Petersen, L. G., Størling, J., Heding, P., Li, S. et al., IL-1beta-induced pro-apoptotic signalling is facilitated by NCAM/FGF receptor signalling and inhibited by the C3d ligand in the INS-1E rat beta cell line. Diabetologia 2006, 49, 1864-1875.
33. Lopez, J. I., Camenisch, T. D., Stevens, M. V., Sands, B. J. et al., CD44 attenuates metastatic invasion during breast cancer progression. Cancer Res. 2005, 65, 6755-6763.
34. Carlier, M. F., Ressad, F., Pantaloni, D., Control of actin dynamics in cell motility. Role of ADF/cofilin. J. Biol. Chem. 1999, 274, 33827-33830.
35. Loisel, T. P., Boujemaa, R., Pantaloni, D., Carlier, M. F., Reconstitution of actin-based motility of Listeria and Shigella using pure proteins. Nature 1999, 401, 613-616.
36. Chan, A. Y., Bailly, M., Zebda, N., Segall, J. E., Condeelis, J. S., Role of cofilin in epidermal growth factor-stimulated actin polymerization and lamellipod protrusion. J. Cell. Biol. 2000, 148, 531-542.
37. Yamaguchi, H., Wyckoff, J., Condeelis, J., Cell migration in tumors. Curr. Opin. Cell Biol. 2005, 17, 559-564.
38. Beckner, M. E., Chen, X., An, J., Day, B. W., Pollack, I. F., Proteomic characterization of harvested pseudopodia with differential gel electrophoresis and specific antibodies. Lab. Invest. 2005, 85, 316-327.
39. Nicholson, R. I., Gee, J. M., Harper, M. E., EGFR and cancer prognosis. Eur. J. Cancer 2001, 37, S9-S15.
40. Yamaguchi, H., Lorenz, M., Kempiak, S., Sarmiento, C. et al., Molecular mechanisms of invadopodium formation: The role of the N-WASP-Arp2/3 complex pathway and cofilin. J. Cell Biol. 2005, 168, 441-452.
41. Lorenz, M., Yamaguchi, H., Wang, Y., Singer, R. H., Condeelis, J., Imaging sites of N-WASP activity in lamellipodia and invadopodia of carcinoma cells. Curr. Biol. 2004, 14, 697-703.
42. Yamaguchi, H., Pixley, F., Condeelis, J., Invadopodia and podosomes in tumor invasion. Eur. J. Cell Biol. 2006, 85, 213-218.
43. Ma, P. C., Tretiakova, M. S., Nallasura, V., Jagadeeswaran, R. et al., Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: Implications for tumour invasion. Br. J. Cancer 2007, 97, 368-377.
44. Birchmeier, C., Birchmeier, W., Gherardi, E., Vande Woude, G. F., Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 2003, 4, 915-925.
45. Ma, P. C., Maulik, G., Christensen, J., Salgia, R., c-Met: Structure, functions and potential for therapeutic inhibition. Cancer Metastasis Rev. 2003, 22, 309-325.
46. Watanabe, T., Tsuda, M., Makino, Y., Ichihara, S. et al., Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines. Mol. Cancer Res. 2006, 4, 499-510.
47. Davies, G., Watkins, G., Mason, M. D., Jiang, W. G., Targeting the HGF/SF receptor c-met using a hammerhead ribozyme transgene reduces in vitro invasion and migration in prostate cancer cells. Prostate 2004, 60, 317-324.
48. Holland, J. D., Kochetkova, M., Akekawatchai, C., Dottore, M. et al., Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells. Cancer Res. 2006, 66, 4117-4124.
49. Tada, H., Hatoko, M., Muramatsu, T., Shirai, T., Expression of E-cadherin in skin carcinomas. J. Dermatol. 1996, 23, 104-110.
50. Madhavan, M., Srinivas, P., Abraham, E., Ahmed, I. et al., Cadherins as predictive markers of nodal metastasis in breast cancer. Mod. Pathol. 2001, 14, 423-427.
51. Grossman, H. B., Lee, C., Bromberg, J., Liebert, M., Expression of the alpha6beta4 integrin provides prognostic information in bladder cancer. Oncol. Rep. 2000, 7, 13-16.
52. Ke, J. J., Shao, Q. S., Ling, Z. Q., Expression of E-selectin, integrin beta1 and immunoglobulin superfamily member in human gastric carcinoma cells and its clinicopathologic significance. World J. Gastroenterol. 2006, 12, 3609-3611.
53. Kajita, M., Itoh, Y., Chiba, T., Mori, H. et al., Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J. Cell Biol. 2001, 153, 893-904.
54. Yamane, N., Tsujitani, S., Makino, M., Maeta, M., Kaibara, N., Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer. Oncology 1999, 56, 232-238.
55. Iurisci, I., Tinari, N., Natoli, C., Angelucci, D. et al., Concentrations of galectin-3 in the sera of normal controls and cancer patients. Clin. Cancer Res. 2000, 6, 1389-1393.
56. Asgeirsson, K. S., Agrawal, A., Allen, C., Hitch, A. et al., Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients. Breast Cancer Res. 2007, 9, R75.
57. Quaranta, M., Divella, R., Daniele, A., Di Tardo, S. et al., Epidermal growth factor receptor serum levels and prognostic value in malignant gliomas. Tumori 2007, 93, 275-280.
58. Zhao, Y., Bachelier, R., Treilleux, I., Pujuguet, P. et al., Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases. Cancer Res. 2007, 67, 5821-5830.
59. Tucker, G. C., Integrins: Molecular targets in cancer therapy. Curr. Oncol. Rep. 2006, 8, 96-103.
60. Shintani, Y., Fukumoto, Y., Chaika, N., Grandgenett, P. M. et al., ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression. Int. J. Cancer 2008, 122, 71-77.
61. Normanno, N., Gullick, W. J., Epidermal growth factor receptor tyrosine kinase inhibitors and bone metastases: Different mechanisms of action for a novel therapeutic application? Endocr. Relat. Cancer 2006, 13, 3-6.
62. Koon, E. C., Ma, P. C., Salgia, R., Welch, W. R. et al., Effect of a c-Met-specific, ATP-competitive small-molecule inhibitor SU11274 on human ovarian carcinoma cell growth, motility, and invasion. Int. J. Gynecol. Cancer 2007 (Epub ahead of print), doi: 10.1111/j.1525-1438.2007.01135.x.
63. Kim, S. Y., Lee, C. H., Midura, B. V., Yeung, C. et al., Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases. Clin. Exp. Metastasis 2008, 25, 201-211.
64. Zahedi, R. P., Moebius, J., Sickmann, A., Two-dimensional BAC/SDS-PAGE for membrane proteomics. Subcell. Biochem. 2007, 43, 13-20.
65. Coughenour, H. D., Spaulding, R. S., Thompson, C. M., The synaptic vesicle proteome: A comparative study in membrane protein identification. Proteomics 2004, 4, 3141-3155.
66. Helling, S., Schmitt, E., Joppich, C., Schulenborg, T. et al., 2-D differential membrane proteome analysis of scarce protein samples. Proteomics 2006, 6, 4506-4513.
67. Moebius, J., Zahedi, R. P., Lewandrowski, U., Berger, C. et al., The human platelet membrane proteome reveals several new potential membrane proteins. Mol. Cell. Proteomics 2005, 4, 1754.
68. Cao, R., Li, X., Liu, Z., Peng, X. et al., Integration of a twophase partition method into proteomics research on rat liver plasma membrane proteins. J. Proteome Res. 2006, 5, 634-642.
69. Liang, X., Zhao, J., Hajivandi, M., Wu, R. et al., Quantification of membrane andmembrane-bound proteins in normal and malignant breast cancer cells isolated from the same patient with primary breast carcinoma. J. Proteome Res. 2006, 5, 2632-2641.
70. Ramus, C., Gonzalez de Peredo, A., Dahout, C., Gallagher, M. et al., An optimized strategy for ICAT quantification of membrane proteins. Mol. Cell. Proteomics 2006, 5, 68-78.
71. Beck, S., Sakurai, T., Eustace, B. K., Beste, G. et al., Fluorophore-assisted light inactivation: A high-throughput tool for direct target validation of proteins. Proteomics 2002, 2, 247-255.
72. Eustace, B. K., Sakurai, T., Stewart, J. K., Yimlamai, D. et al., Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat. Cell Biol. 2004, 6, 507-514.
73. Cross, M., Nguyen, T., Bogdanoska, V., Reynolds, E. et al., A proteomics strategy for the enrichment of receptor-associated complexes. Proteomics 2005, 5, 4754-4763.
74. Bene, L., Kanyári, Z., Bodnár, A., Kappelmayer, J. et al., Colorectal carcinoma rearranges cell surface protein topology and density in CD41 T cells. Biochem. Biophys. Res. Commun. 2007, 361, 202-207.
75. Wu, C. C., MacCoss, M. J., Howell, K. E., Yates, J. R., III, A method for the comprehensive proteomic analysis of membrane proteins. Nat. Biotechnol. 2003, 21, 532-538.
76. Cao, R., He, Q., Zhou, J., He, Q. et al., High-throughput analysis of rat liver plasma membrane proteome by a nonelectrophoretic in-gel tryptic digestion coupled with mass spectrometry identification. J. Proteome Res. 2008, 7, 535-545.
77. Chick, J. M., Haynes, P. A., Molloy, M. P., Bjellqvist, B. et al., Characterization of the rat liver membrane proteome using peptide IPG IEF. J. Proteome Res. 2008, 7, 1036-1045.